Even after Anthropic's claim, there is a long way to go before AI can reliably produce a CRISPR-like gene editing tool.

AI giant announces discovery amid global debate about how to safeguard against catastrophic risks.

Anthropic announced today that its Claude artificial intelligence (AI) system identified a previously unknown biological system in the DNA of viruses that infect bacteria. The press release is the ...

Experts at the company don't know what the newfound system does, so its potential utility in biology—if any—remains unclear.

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance. In a potential breakthrough for tackling antibiotic resistance, researchers from the ...

A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics and treatments safer, more precise, and more affordable, while opening the ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

Gene editing companies traded lower on Wednesday after Anthropic (ANTHRO) announced that its AI model Claude has “autonomously discovered” a new enzyme system similar to the gene-editing tool CRISPR.

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing "copilot" ...

The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for ...

Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively cured through the use of CRISPR gene editing technology. But the rollout of ...

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...